Jump to content
This site uses cookies. Continued use is acceptance of our Terms of Use and Privacy Policy. More Info... ×
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Scott Adams
    Scott Adams

    Making Wheat Safe for People with Celiac Disease: A New Genetic Breakthrough

    Reviewed and edited by a celiac disease expert.

    This research represents a significant step toward producing wheat that is safer for people at risk of celiac disease—without sacrificing the quality of the final baked product.

    Making Wheat Safe for People with Celiac Disease: A New Genetic Breakthrough - Winter Wheat by Malcolm Carlaw is licensed under CC BY 2.0.
    Caption:
    Winter Wheat by Malcolm Carlaw is licensed under CC BY 2.0.

    Celiac.com 07/11/2025 - Celiac disease is an immune condition that affects around 1 in 100 people worldwide. It is triggered when genetically susceptible individuals consume gluten—a group of proteins found in wheat, barley, and rye. These proteins, particularly parts of wheat called gliadins and glutenins, contain small sequences of amino acids known as epitopes. In people with celiac disease, these epitopes activate the immune system and cause inflammation in the small intestine, leading to symptoms like stomach pain, diarrhea, and fatigue. The only current treatment is a strict gluten-free diet.

    However, avoiding gluten is challenging and costly. Even trace amounts can cause harm, and people often struggle with unintentional exposure. Because gluten is so important for the texture and structure of bread, completely removing it from wheat is not a practical solution for mass food production. Researchers have instead been exploring whether it’s possible to reduce or remove only the parts of gluten that are most harmful, while preserving its functional qualities for baking.

    A Closer Look at Wheat Proteins and Their Role

    Celiac.com Sponsor (A12):
    Wheat gluten is made up of two main protein groups: glutenins and gliadins. Glutenins help form the stretchy, elastic network that gives dough its strength. Gliadins contribute to the dough’s ability to expand. Gliadins are generally more problematic for people with celiac disease because they contain more of the immunogenic epitopes—the parts that trigger the immune reaction.

    Of these, one particular group called alpha-gliadins stands out. They are not as critical for baking performance but are heavily loaded with the harmful sequences known to trigger strong immune responses in most people with celiac disease. These alpha-gliadins are encoded by three regions in the wheat genome, each located on a different version of chromosome 6: A, B, and D.

    The Breakthrough: Targeted Deletions in Wheat Genes

    In this study, researchers used a technique called gamma radiation to selectively delete sections of the wheat genome that include the genes for alpha-gliadins. They developed three versions of wheat with these deletions, each removing alpha-gliadins from one of the three chromosomes. The deletions were labeled Δgli-A2, Δgli-B2, and Δgli-D2, referring to the respective chromosomes affected.

    Of the three, the Δgli-D2 deletion had the most dramatic effects:

    • It removed a significant number of harmful epitopes, including some of the most potent ones known as the 17-mer and 33-mer sequences.
    • It improved gluten strength and breadmaking quality.
    • It did not harm the grain’s yield, protein content, or dough elasticity.

    Interestingly, alpha-gliadins from chromosome 6D contain a unique structural feature—seven cysteine residues—that allow them to interact with the gluten network in a way that may actually weaken it. Removing these particular proteins seems to make the gluten network stronger, not weaker.

    Breadmaking Without the Harmful Parts

    The Δgli-D2 deletion led to stronger gluten and better baking performance. This was not expected, as removing parts of gluten could potentially weaken dough quality. However, it turns out that some alpha-gliadins may act like “chain terminators” in the gluten network, preventing it from growing stronger. Eliminating them allows the glutenins to form longer and more robust protein chains, leading to better dough properties.

    Even more importantly, this genetic change removed around 81 percent of the most harmful gluten epitopes from the alpha-gliadin family. This could significantly reduce the risk that wheat consumption would trigger the immune response in people genetically at risk for celiac disease.

    Combining Deletions for Bigger Impact

    While Δgli-D2 had the most benefit, combining it with Δgli-A2 (removing alpha-gliadins from chromosome 6A) offered additional reduction in harmful epitopes, without compromising wheat quality. However, attempting to remove alpha-gliadins from all three chromosomes (adding Δgli-B2) led to sterile plants that could not reproduce. This limitation arises because wheat is a polyploid—meaning it has multiple sets of chromosomes—and deleting all versions of an important gene can lead to problems in plant development.

    To further reduce the toxicity of wheat for people with celiac disease, scientists are also exploring deletions in other parts of the wheat genome that encode different kinds of gliadins, such as omega- and gamma-gliadins. Some promising results have been achieved using gene editing tools like CRISPR, which allows precise removal of these toxic segments without affecting other important traits.

    Why This Study Matters

    This research represents a significant step toward producing wheat that is safer for people at risk of celiac disease—without sacrificing the quality of the final baked product. Rather than attempting to eliminate gluten entirely, which would ruin bread’s texture and taste, the researchers have found a way to remove the most harmful components while maintaining and even improving the wheat’s baking performance.

    Importantly, this modified wheat is publicly available and could be used by breeders and food companies to develop new varieties of bread and pasta that are lower in celiac-triggering proteins. While these products would still not be completely safe for people with celiac disease, they could help reduce the overall population burden of the condition by lowering the chances of triggering it in genetically susceptible individuals.

    In the future, combining these deletions with other strategies—such as further CRISPR modifications or enzyme treatments—might make it possible to create wheat-based foods that are significantly less toxic, or even fully safe, for people with celiac disease.

    Conclusion: A Promising Path Forward

    The study shows that it is possible to selectively remove the most dangerous parts of wheat gluten while improving bread quality. By deleting specific genes for alpha-gliadins, particularly those on chromosome 6D, researchers have created a type of wheat that contains far fewer celiac-triggering components and performs better in baking. For individuals with celiac disease, this work opens the door to a future where wheat-based products may one day be safer to consume, reducing health risks and improving quality of life. Although more work is needed, especially to remove all problematic proteins, this study marks a promising advance in the quest to make wheat healthier for everyone.

    Read more at: link.springer.com


    User Feedback

    Recommended Comments

    There are no comments to display.



    Create an account or sign in to comment

    You need to be a member in order to leave a comment

    Create an account

    Sign up for a new account in our community. It's easy!

    Register a new account

    Sign in

    Already have an account? Sign in here.

    Sign In Now

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Scott Adams

    Scott Adams was diagnosed with celiac disease in 1994, and, due to the nearly total lack of information available at that time, was forced to become an expert on the disease in order to recover. In 1995 he launched the site that later became Celiac.com to help as many people as possible with celiac disease get diagnosed so they can begin to live happy, healthy gluten-free lives.  He is co-author of the book Cereal Killers, and founder and publisher of the (formerly paper) newsletter Journal of Gluten Sensitivity. In 1998 he founded The Gluten-Free Mall which he sold in 2014. Celiac.com does not sell any products, and is 100% advertiser supported.


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Jefferson Adams
    Researchers Use CRISPR/Cas9 to Produce Low Gluten Wheat Strains
    Celiac.com 10/25/2017 - For people with celiac disease, eating gluten proteins from wheat, barley, and rye triggers an auto-immune response, and the accompanying physical symptoms.
    A team of researchers recently set out to engineer low-gluten wheat strains that also have low-reactivity for people with celiac disease. To meet their goals, the team designed two sgRNAs to target a conserved region adjacent to the coding sequence for the 33-mer in the -gliadin genes. They then sought to evaluate the results.
    The research team included Susana Sánchez-León, Javier Gil-Humanes, Carmen V. Ozuna, María J. Giménez, Carolina Sousa, Daniel F. Voytas, and Francisco Barro. They are variously affiliated with the Departamento de Mejora Genética Vegetal, Instituto de Agricultura Sostenible (IAS-CSIC...


    Jefferson Adams
    Can Researchers Use Gene-Editing to Make Gluten-Safe Wheat?
    Celiac.com 02/11/2019 - Researchers have shown that CRISPR-Cas9 gene-editing technology can be used to remove epitopes from gliadin protein in gluten. These molecules trigger the adverse immune response seen in people with celiac disease. However, will Europe’s strict GM rules prevent this discovery from being used to create new gluten-free products for people with celiac disease?
    Researchers at Wageningen University in the Netherlands, and at the National Institute of Agricultural Botany (NIAB) in the UK, have shown that CRISPR-Cas9 gene-editing technology can be used to remove epitopes from gliadin protein in gluten. Gluten contains an assortment glutenin and gliadin proteins. Most of these gliadins and many of the glutenins contain immunogenic epitopes that trigger an immune r...


    Jefferson Adams
    Are We on The Verge of Gluten-Free Wheat?
    Celiac.com 06/10/2019 - Gluten-free wheat is surely an oxymoron, right? How can wheat be gluten-free? Well, researchers are currently creating wheat strains that exclude the proteins that trigger immune reactions in people with celiac disease and gluten-sensitivity. The result could be the first wheat that is safe for people with celiac disease.
    The omega-1,2 gliadins are a group of wheat gluten proteins that contain immunodominant epitopes for celiac disease and also have been associated with food allergies. The research team recently set out to reduce the toxicity of gliadin proteins in wheat.
    To reduce the levels of these proteins in the flour, the team used an RNA interference plasmid, which targeted a 141 bp region at the 5′ end of an omega-1,2 gliadin gene, to genetically tra...


    Scott Adams
    CRISPR/Cas9: A Game-Changer for Gluten-Free Wheat
    Celiac.com 10/21/2024 - Wheat has been a staple in human diets for centuries, but for individuals with celiac disease and gluten sensitivities, consuming wheat can lead to serious health complications. The culprit? Gluten, particularly the gliadin fractions found in wheat, which trigger immune responses in those affected by celiac disease. A new study presents groundbreaking advancements in the field of gluten-free wheat production. Researchers have successfully used CRISPR/Cas9 technology to target and reduce gluten content by editing the genes responsible for the immunogenic gliadin proteins.
    Targeting Gliadin Genes with CRISPR/Cas9
    The researchers in this study focused on two major groups of gliadin proteins: gamma (γ) and omega (ω) gliadins. These proteins are known t...


  • Recent Activity

    1. - Scott Adams replied to Jmartes71's topic in Dermatitis Herpetiformis
      1

      Natural remedies

    2. - Scott Adams replied to miguel54b's topic in Related Issues & Disorders
      1

      Gluten and short-term memory.

    3. - Scott Adams replied to Suze046's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      1

      Reintroduction of Gluten

    4. - Scott Adams replied to Rejoicephd's topic in Coping with Celiac Disease
      2

      Draft gluten-free ciders… can they be trusted ?

    5. - Scott Adams replied to Mykidzz3's topic in Gluten-Free Foods, Products, Shopping & Medications
      1

      High Cost of Gluten-Free Foods


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      131,369
    • Most Online (within 30 mins)
      7,748

    Nick H.
    Newest Member
    Nick H.
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      121.4k
    • Total Posts
      1m

  • Celiac.com Sponsor (A22):





  • Celiac.com Sponsor (A21):



  • Popular Now

    • Celiacpartner
      8
    • SEQ
      4
    • barb simkin
      9
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...